Ginkgo Bioworks shares are trading higher after the company announced a collaboration with Merck focused on improving biologic manufacturing.
Portfolio Pulse from Benzinga Newsdesk
Ginkgo Bioworks has announced a collaboration with Merck to improve biologic manufacturing, leading to a rise in Ginkgo Bioworks' shares.

August 07, 2023 | 11:48 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Ginkgo Bioworks' shares are trading higher after the company announced a collaboration with Merck.
The announcement of the collaboration with Merck, a major player in the pharmaceutical industry, is a positive development for Ginkgo Bioworks. This partnership could potentially lead to advancements in biologic manufacturing, which would be beneficial for Ginkgo Bioworks. As a result, investors are reacting positively, leading to a rise in the company's shares.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100